GlassScriptPhysician profile
Richard Eugene Boyer
NPI 1093434847
$2,425.67
in general payments reported to CMS, 2019-2025
20 companies · $713 in 2025
The $713 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $601 · 2024: $1,111 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,425.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $688.92 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $277.53 | 2023-2025 | Watchman Access System, Watchman Flx, Watchman |
| Merck Sharp & Dohme LLC | $245.95 | 2023-2024 | Verquvo, Winrevair |
| Kestra Medical Technology Services, INC. | $244.08 | 2024-2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $216.66 | 2023-2024 | Inspiris Resilia Aortic Valve, Sapien 3 Ultra Resilia |
| Abiomed | $187.63 | 2023-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $111.10 | 2023-2024 | Farxiga |
| Terumo Medical Corporation | $82.67 | 2023-2024 | Azur Cx Detachable, Heartrail, Glidewire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.21 | 2023-2025 | Lifevest |
| Atricure, INC. | $71.00 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $50.20 | 2023-2025 | Iovera, Exparel, Zilretta |
| Lexicon Pharmaceuticals, INC. | $40.88 | 2023 | Inpefa |
| Amgen INC. | $21.35 | 2023 | Repatha |
| Scpharmaceuticals INC. | $20.63 | 2024 | |
| Cvrx, INC. | $19.54 | 2024 | Barostim Neo System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $19.27 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.87 | 2023 | Jardiance |
| W. L. Gore & Associates, INC. | $13.66 | 2025 | Gore Cardioform Septal Occluder |
| Azurity Pharmaceuticals, INC. | $13.41 | 2024 | Edarbyclor |
| Impulse Dynamics (USA) INC. | $13.11 | 2023 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Boyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.